Elsevier

Journal of Immunological Methods

Volume 472, September 2019, Pages 25-34
Journal of Immunological Methods

Optimisation of multiplex immunofluorescence for a non-spectral fluorescence scanning system

https://doi.org/10.1016/j.jim.2019.06.011Get rights and content

Abstract

The use of multi-colour immunofluorescence (IF) for immunophenotyping in formalin-fixed paraffin-embedded tissue sections is gaining popularity worldwide. This technique allows for the simultaneous detection of multiple markers on the same tissue section, thereby yielding more complex information than is possible by chromogenic immunohistochemistry (IHC). However, many commercially-available multiplex IF kits are designed for use in conjunction with a multispectral imaging system, to which many research groups have limited access. Here we present two 5-colour IF panels designed for T cell characterisation in human colorectal tissue, which can be imaged using a non-spectral fluorescence slide scanner with standard band-pass filters. We describe the optimisation process and the key considerations in developing a multiplex fluorescence assay, and discuss some of the advantages and disadvantages of using multiplex IF with a non-spectral imaging system.

Introduction

In recent years, it has become evident that the type, density and/or spatial distribution of immune cells in tumour specimens is potentially valuable for predicting cancer prognosis and response to treatment (Schnell et al., 2018). In colorectal cancer, tumour-infiltrating T cell density can add important prognostic information over traditional pathological staging (Mlecnik et al., 2011) and efforts are underway to standardise T cell assessment for inclusion in routine pathology review (Galon et al., 2014; Pages et al., 2018). However, chromogenic immunohistochemistry (IHC), the gold standard in pathology for analysing proteins in tissues, can only assess one or two markers concurrently and is therefore unlikely to yield sufficiently detailed insights into complex interactions between multiple cells. This has driven the development of different multiplexed technologies that allow for simultaneous assessment of multiple markers on the same tissue section (Parra et al., 2019).

Multiplex immunofluorescence (IF) staining techniques using tyramide-signal amplification (TSA) are gaining popularity worldwide, as they allow researchers to use primary antibodies from the same species and thereby select antibodies solely on the basis of their performance (Stack et al., 2014; Blom et al., 2017; Feng et al., 2017; Parra et al., 2017; Gorris et al., 2018). Traditionally, multiplex IF or IHC has relied on using primary antibodies raised in different species to avoid cross-reactivity on application of fluorescently-labelled secondary antibodies (van der van der Loos, 2008). The range of host species in which commercially-available primary antibodies are produced therefore limits the value of this technique (most anti-human antibodies being raised in mouse, rabbit or goat). Multiplex IF using TSA involves sequential staining and stripping steps whereby deposited fluorophores remain on the tissue surface but antibody complexes are removed, allowing for the use of multiple primary antibodies raised in the same species in a single staining panel (Toth and Mezey, 2007; Zhang et al., 2017; Buchwalow et al., 2018). While multiplex staining with primary antibodies of the same species can be achieved using TSA-free techniques, such as those using Fab fragments (Brown et al., 2004) or antibodies of different subclasses (Ijsselsteijn et al., 2019), TSA is an attractive alternative given the added benefits of signal amplification, allowing detection of low expressed antigens.

Many commercial TSA-based multiplex IF staining kits, such as the Perkin Elmer OPAL kits, are recommended for use with a multispectral microscopy system for image acquisition and analysis. These systems capture many narrow bandwidths of light and use algorithms to separate spectral curves of multiple fluorophores. However, many research groups have limited access to such systems. Traditional fluorescence detection using band pass filters can be used to distinguish multiple markers (albeit not as many) and are more widely available, but their utility for analysing multiplex IF staining is relatively unexplored. Since clinical research projects often involve assessment of large tissue areas, such as tissue microarrays (TMAs), or multiple whole tissue sections, use of a scanning system rather than a single field of view fluorescence microscope is usually preferable (Isse et al., 2012).

Here we describe our experience optimising two 5-colour immunofluorescence panels (four IF markers plus DAPI) combining TSA and indirect immunofluorescence for the assessment of tumour-infiltrating lymphocytes (TILs) in formalin-fixed, paraffin-embedded (FFPE) colorectal tissue (TMAs and whole tissue sections), for imaging on a fluorescence slide scanner with standard bandpass filters. We discuss some of the major steps and key considerations in optimising a TSA-based assay and developing multiplex assays.

Section snippets

Sample preparation

The use of tissue for this work was approved by the St John of God Health Care Human Research Ethics Committee. All staining was performed using FFPE human tissue sections (4 μm thickness). Sections were dewaxed and rehydrated through graded alcohol and xylene washes. Antigen retrieval was performed in Tris-EDTA buffer (pH 9.0) using a microwave pressure cooker (Nordic Ware Microwave Tender Cooker 2.5 Quart; Amazon.com) and a microwave oven at 770 W power. The retrieval buffer was pre-heated

Optimising TSA-based fluorescence IHC staining

A TSA-based assay, like chromogenic IHC, involves application of a primary antibody specific to the epitope of interest, followed by a horseradish peroxidase (HRP)-conjugated secondary. The HRP is then used to catalyse the deposition of fluorescently-labelled tyramide molecules that bind covalently to the target epitope and surrounding local area, resulting in signal amplification (Krieg and Halbhuber, 2010). These tyramide molecules remain bound to the tissue following heat or chemical

Discussion

TSA-based multiplex IF offers several advantages over traditional chromogenic IHC, including the ability to detect multiple markers on the same tissue section, without the requirement for primary antibodies to be raised in different species, and to detect co-localisation of proteins in the same cellular compartment. Most commercial TSA-based multiplex IF kits are recommended for use with a multispectral imaging and analysis system due to their ability to accurately resolve multiple spectral

Competing interests

The authors declare no competing interests.

Acknowledgements

The authors would like to thank Raelene Endersby of the Telethon Kids Institute for facilitating access to the fluorescence scanning system, Paul Rigby and Alysia Hubbard of the Centre for Microscopy, Characterisation and Analysis at the University of Western Australia (a facility funded by the University and the State and Commonwealth Governments), and Brad Hope of Coherent Scientific, for their valuable advice and assistance.

Funding

This work was funded by the Tonkinson Colorectal Cancer Research Fund. The fluorescence scanning system was purchased for Telethon Kids Institute with funding from Bright Blue – The Police Commissioner's Fund for Sick Kids. StrataQuest image analysis software was funded by the Tonkinson Colorectal Cancer Research Fund and the St John of God Foundation.

References (29)

  • J.K. Brown et al.

    Primary antibody-fab fragment complexes: a flexible alternative to traditional direct and indirect immunolabeling techniques

    J. Histochem. Cytochem.

    (2004)
  • Z. Feng et al.

    Multiparametric immune profiling in HPV- oral squamous cell cancer

    JCI Insight

    (2017)
  • J. Galon et al.

    Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

    J. Pathol.

    (2014)
  • N.S. Goldstein et al.

    Recommendations for improved standardization of immunohistochemistry

    Appl. Immunohistochem. Mol. Morphol.

    (2007)
  • Cited by (0)

    1

    These authors contributed equally to this work.

    View full text